In this report, we cover catalysts from 35 drugs, devices, diagnostics, and deals expected to ...
€4,473.08
Molecular diagnostics is being applied to an increasingly wide range of applications in infectious disease, ...
€4,473.08
PharmaVitae explores Seattle Genetics’ prescription pharmaceutical performance and outlook over 2019–29. PharmaVitae analyses include quarterly ...
€2,825.10
This Market Spotlight report covers the chemotherapy-induced anemia market, comprising key marketed and pipeline drugs, ...
€1,241.16
This Market Spotlight report covers the Zika virus market, comprising key pipeline therapies, clinical trials, ...
€1,241.16
This Market Spotlight report covers the pancreatic cancer market, comprising key marketed and pipeline drugs, ...
€1,241.16
This Market Spotlight report covers the Hepatitis B market, comprising key marketed and pipeline drugs, ...
€1,241.16
This Market Spotlight report covers the Obesity market, comprising key marketed and pipeline drugs, clinical ...
€1,241.16
PharmaVitae explores GlaxoSmithKline’s prescription pharmaceutical performance and outlook over 2019–29. PharmaVitae analyses include quarterly earnings ...
€2,825.10
PharmaVitae explores Vertex’s prescription pharmaceutical performance and outlook over 2019–29. PharmaVitae analyses include quarterly earnings ...
€2,825.10
This Market Spotlight report covers the Erectile Dysfunction market, comprising key pipeline and marketed drugs, ...
€1,241.16
This Market Spotlight report covers the Hypogonadism market, comprising key marketed and pipeline drugs, clinical ...
€1,241.16
This Market Spotlight report covers the Duchenne muscular dystrophy market, comprising key pipeline and marketed ...
€1,241.16
This Market Spotlight report covers the Sickle Cell Anemia market, comprising key marketed and pipeline ...
€1,241.16
This Market Spotlight report covers the cervical cancer market, comprising key pipeline and marketed drugs, ...
€1,241.16
Osteoporosis is the most common metabolic bone disease, and is characterized by compromised bone strength ...
€20,717.40
Bladder cancer is the fifth most common cancer in Europe and the ninth most common ...
€20,717.40
Rheumatoid arthritis (RA) is a chronic, systemic, inflammatory autoimmune disease which primarily damages the joints, ...
€20,717.40
Pulmonary arterial hypertension is one of a group of rare and life-threatening diseases collectively known ...
€20,717.40
PharmaVitae explores Sanofi’s prescription pharmaceutical performance and outlook over 2019–29. PharmaVitae analyses include quarterly earnings ...
€2,825.10
PharmaVitae explores Merck & Co’s prescription pharmaceutical performance and outlook over 2019–29. PharmaVitae analyses include ...
€2,825.10
PharmaVitae explores Eli Lilly’s prescription pharmaceutical performance and outlook over 2019–29. PharmaVitae analyses include quarterly ...
€2,825.10
Sign up to the